ICON to Create Translational Medicine Unit in UK

Monday, December 21, 2009 07:53 AM

Dublin-based contract research organization (CRO) ICON is preparing to open a new hospital-based translational medicine unit in the UK—the result of a partnership with the Central Manchester University Hospitals Foundation (CMFT).

Under the terms of the agreement, signed last summer, ICON will create translational medicine facilities on the newly developed Manchester Royal Infirmary (MRI) campus. The exclusive agreement, which runs until 2012, will help ICON meet increasing demand for hospital-based first-in-human studies.

The new unit—the first deliverable from the ICON-CMFT collaboration—will open in April, and will include 34 beds, an onsite Good Manufacturing Practices pharmacy, a sample handling laboratory and administrative space. It will be connected to MRI’s Accident and Emergency Department.  The unit will also offer environmentally controlled pharmacodynamic study testing suites.

ICON will develop an additional facility on the MRI campus.

The CRO would not comment on the size of its translational medicine business but said translational research is a growth area.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs